David Krumholtz Has Ended Acting Hiatus
The actor returned to the screen following a 30-year career that included public health challenges.
Live Poll
Do you believe actors are fairly compensated for their contributions to major movie studio profits?
U.S. Cancer
Recent news
October 7, 2026
FEMA Granted Funds for Women Firefighter Cancer StudyFlorida State and the University of Arizona will investigate links between gear fit and cancer risks.
October 7, 2026
Researchers Standardized Glioblastoma Organoid PlatformA new reaggregated organoid model improves treatment testing for deadly brain tumors.
October 7, 2026
Researchers Identified Molecule Linked to Prostate CancerA newly discovered tRNA molecule has been found to play a critical role in prostate cancer treatment resistance.
October 7, 2026
Ron Bennington Discussed Colorectal Cancer DiagnosisThe radio host shared his experiences with stage four cancer during a segment on the Today show.
October 7, 2026
Ropeginterferon Alfa-2b Performance AnalyzedA September 2026 meta-analysis compared the efficacy of ropeginterferon alfa-2b against standard polycythemia vera therapies.
October 7, 2026
Melanoma Trial Results Have Been PublishedResearchers found that the drug pepinemab reshaped tumor immune environments in a pilot study.
October 7, 2026
Belantamab Mafodotin Results Reported for MyelomaClinical data showcased a BCMA-directed treatment for patients with relapsed or refractory multiple myeloma.
October 7, 2026
MimiVax Cancer Vaccine Failed Phase 2 Clinical TrialThe experimental treatment SurVaxM missed its primary efficacy endpoint in a study of glioblastoma patients.
October 7, 2026
Perspective Therapeutics Will Present Cancer Drug DataThorvardur Halfdanarson will share clinical results at the NANETS symposium in Las Vegas this November.
October 7, 2026
FDA Updated Safety Strategy for Drug LYNOZYFICFederal regulators issued a new risk notice regarding potential serious side effects for the medication.